AGO2 and prostate cancer: The assay demonstrated significant enrichment of both circ_0001671 and miR-27b-3p in the anti-Ago2 group compared to the anti-IgG group (Fig. 4B), suggesting a regulatory role for circ_0001671 in prostate cancer.